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Abstract  
Background: Comfort may be an appropriate goal in advanced dementia. Longitudinal 
studies on physician decision making and discomfort assessed by direct observation are rare, 
and intravenous rehydration therapy is controversial. 
Methods: To assess treatment decisions and discomfort in patients with advanced dementia 
and pneumonia, and to compare by intravenous rehydration therapy, we used data from the 
observational multicenter Italian End of Life Observatory-Prospective Study On DEmentia 
patients Care (EoLO PSODEC). We analysed 109 episodes of pneumonia which involved 
decisions in 77 nursing home patients with FAST stage 7. We assessed decisions, decision 
making, and treatments every fortnight. Trained observers assessed discomfort with the 
Discomfort Scale-Dementia Alzheimer Type (DS-DAT).  
Results: Most decisions referred to treatment with antibiotics (90%; 98/109), and intravenous 
rehydration therapy (53%; 58/109), but hospitalization was rare (1%). Selecting decisions 
with antibiotics, with rehydration therapy, the prognosis was more frequently <15 days (34% 
versus 5% without rehydration therapy; P=.001), and a goal to reduce symptoms/suffering 
was more common (96% versus 74%; P=.005) while there was no difference in striving for 
life prolongation (a minority). With rehydration therapy, the decision was more often 
discussed with family rather than communicated only. Mean DS-DAT scores over time 
proximate to the first decision ranged between 9.2 and 10.5.  
Conclusions: Italian nursing home patients with advanced dementia and pneumonia 
frequently received invasive rehydration therapy in addition to antibiotics, however, mostly 
with a palliative intent. Discomfort was high overall and symptom relief may be improved. 
Relations between invasive rehydration therapy and discomfort need further study. 
Keywords palliative care, comfort, dementia, pneumonia, fluid therapy, long-term care
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Introduction 
To improve comfort is an appropriate treatment goal for patients with advanced dementia.1 
However, patients with dementia frequently develop pneumonia and often die from it,2,3 while 
pneumonia has been associated with high levels of discomfort.4,5  Observational studies in 
nursing home patients with dementia and pneumonia have shown that hydration status and 
antibiotics are associated with (dis)comfort and survival4-8 and hydration might affect survival 
more than antibiotics.9  
 However, it is unclear if rehydration therapy affects discomfort or survival. In the 
dying phase, the use of rehydration therapy in patients with dementia, especially intravenous 
rehydration, is controversial.1,10 For example, in an international Delphi study with experts 
from 23 countries, the experts achieved full consensus on almost all aspects of palliative care 
in dementia, but not on rehydration being inappropriate in the dying phase.1 Lack of 
consensus may be indicated also by considerable variability in treatment practice in dementia 
at the end of life cross-nationally.11-13 Whereas parenteral rehydration and tube feeding are 
rarely provided to nursing home patients with dementia in the Netherlands,8,14 in Italy, many 
nursing home patients with advanced dementia die while receiving parenteral rehydration and 
tube feeding,11 and specific guidelines are lacking. 
 Our goal was to describe practice of treatment of pneumonia in Italian nursing home 
residents with advanced dementia in terms of decisions and decision making including 
treatment goals and discomfort. We compared decisions and decision making with and 
without intravenous rehydration therapy, and we described directly observed discomfort at 
several intervals close to treatment. 
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Methods 
We used data from the prospective observational multicenter Italian End of Life Observatory 
- Prospective Study On DEmentia patients Care (EoLO PSODEC, June 2007 to May 2009) 
described elsewhere.15,16 The goal of the EoLO PSODEC cohort study was to describe, over 
time, end-of-life critical decisions taken for patients with advanced-stage dementia, 
treatments, and discomfort. Enrolled patients had a Functional Assessment Staging Tool 
(FAST) score of 7 (sub stages a to f)17 and an expected survival ≥ 2 weeks at baseline (upon 
enrolment) according to their primary doctor’s clinical judgment. Data were collected every 
14 days until death or up to six months. EoLO PSODEC focused on critical decisions, i.e., 
decisions perceived as critical by the physician because of possible impact on survival or 
quality of life, including on rehydration therapy and antibiotics (“a critical decision is the 
decision to start, withdraw, or withhold a treatment that the physician and/or the health care 
team perceive as critical to a patient’s survival and/or quality of life”16). Trained nursing staff 
coordinating the project’s data collection interviewed the physician on each critical decision. 
The study protocol was approved 18 January 2008 by the ethics committee of the University 
of Reggio Emilia-Modena (protocol number 145/CE). The relatives provided informed 
consent for use of data for the study. 
 The study enrolled 496 patients from 34 nursing homes in the Lombardia region (315 
patients) and home care in two provinces of Emilia-Romagna Region (181 patients). We 
selected critical decisions around pneumonia in nursing home patients as the long-term care 
context differs from community settings (Figure 1). The physicians in nursing homes were on 
the staff and intravenous fluid therapy was always available in the nursing homes.  
 We report demographics, dementia type and FAST stage from the baseline 
assessment. At the time of a decision (the main unit of analyses) that was critical to the 
patient’s survival or quality of life, the physicians reported prognosis (whether less than 15 
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days), any treatments started or stopped from a pre-structured list (including those not specific 
to treatment of the pneumonia such as blood transfusion). The list also included an open-
ended option for any other treatments. The physician also reported treatment goals (aims), 
communication with family, and their perception of decision-making authority.   
 Discomfort was assessed every fortnight (not specifically timed around decisions) 
with the validated Discomfort Scale-Dementia Alzheimer Type (DS-DAT)18,19 by trained 
nurses. The theoretical range of the DS-DAT is 0 to 27, and scores during acute illness are 
generally normally distributed even though the highest score is rarely obtained as it implies 
discomfort and lack of comfort expressed extremely on all of 9 items.  
 We compared decisions and decision making between patients treated with and 
without intravenous rehydration therapy using Chi-square or Fisher exact tests (treatment and 
aims) and t-tests or non-parametric Mann-Whitney U test (number of aims) as appropriate. 
Antibiotics were controlled for (by stratifying and selection of those treated with antibiotics 
for analyses, related to the distribution; Figure 1) because antibiotics have been associated 
with more symptoms in the period around treatment by nursing report7 but also with lower 
observed discomfort following treatment.5 A power analysis based on data on discomfort 
levels observed 3 days after the treatment decision obtained in a Dutch study showed that to 
compare discomfort between two groups, 42 decisions in each group were needed to detect a 
clinically relevant difference of 3 DS-DAT points with 80% power and 90% two-sided 
confidence intervals, and in case of 95% confidence intervals, 53 to compare between groups 
and 29 for paired analyses of change over time within treatment group. Because power was 
insufficient to compare different groups or the same group over time, we only describe the 
course of discomfort. For this, to avoid analyses of overlapping periods around multiple 
decisions per patient, we selected the first decisions in patients who did not receive 
rehydration therapy at baseline (Figure 1).  
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Results  
There were 109 decisions (cases of pneumonia) in 77 nursing home patients residing in 28 
nursing homes. In 58% of the cases (61/106, 3 missing values), the decision was taken by a 
female physician, and the mean age was 43.8 (SD 7.8, 3 missing values). 
 Most decisions (90%; 98/109) referred to starting treatment with antibiotics (Figure 1). 
In 9 cases, antibiotics were not started, and in 2 cases, they were stopped. In 53% (58/109) of 
cases, there was a decision to start intravenous rehydration therapy (Table 1, left column). In 
11% of cases (12/109), patients had intravenous rehydration therapy at baseline. 
Hypodermoclysis, tube feeding, and hospitalization were rare (up to a few percent only). 
However, (terminal) sedation and other potentially comfort-enhancing medical interventions 
were rare too, in spite of reducing symptoms/suffering being a treatment goal for the large 
majority of patients (89%) whether or not accompanied by a goal to prolong life (34% of total 
decisions; Table 2, left column). In 70% of cases there was a single goal, and in the other 
cases two to four goals. The mean number of goals per decision was 1.4 but in more than half 
of the cases, there was a single goal (median 1; Table 2). 
 The decision was often communicated to family, but less often discussed with them 
(89% and 49%, respectively, Table 2). The final decision was taken by the physician alone in 
two-thirds (67%) of cases, and in other cases, it was mostly the health care team (23%). The 
physician was never guided by (previous) patient wishes, and rarely (7%) by family wishes. 
The physician found the treatment decisions corresponded with what the physician felt as the 
right thing to do in all but 2 cases (no reason provided; 6 missing values, not in Table). 
 Because the large majority of cases was treated with antibiotics, we restricted the 
comparison of treatment decisions between patients who did not and did receive intravenous 
rehydration therapy to those treated with antibiotics (right columns in Table 1), excluding also 
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patients who received intravenous rehydration therapy at baseline. Demographics and 
dementia type did not differ, but patients who received intravenous rehydration therapy more 
frequently had a poor prognosis at the time of the decision as perceived by the physician (34% 
versus 5%; P=.001). Treatment other than antibiotics and intravenous rehydration was rare 
and comparisons therefore often not meaningful, but goals of care differed in that the most 
frequent goal, to reduce symptoms/suffering, applied to almost all cases treated with 
intravenous rehydration therapy (96%) whereas this was about three-quarters (74%) in 
untreated cases (P=.005). Most decisions did not aim at life prolongation and there was no 
difference between cases treated with and without intravenous rehydration. Further, the 
patterns regarding the physicians taking the decisions and communicating it to families did 
not differ, but a decision to start intravenous rehydration therapy was more frequently 
discussed with family (54% versus 27%, P=.01). 
 The mean DS-DAT score in the period before the first decision, for all cases of 
pneumonia, was 9.6 (SD 6.6); it was 10.5 (SD 7.1) in the period of the decision, and 9.2 (SD 
6.6) in the period after the decision (Figure 2, solid line). Figure 2 visualizes that the means 
did not vary much over time and also that the DS-DAT score patterns did not differ much by 
having received intravenous rehydration therapy. 
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Discussion 
Pneumonia in Italian nursing home patients with advanced dementia was frequently but not 
always (90%) treated with antibiotics, and over half of the patients (53%) received 
intravenous rehydration therapy. Other treatments, however, including sedation−but also 
hospitalization−were notably rare. Focusing on intravenous rehydration therapy in antibiotic-
treated patients, strikingly, rehydration therapy was more common when the patient was near 
death according to the physician (prognosis <15 days, 34% vs. 5%). Moreover, for almost all 
(96%) of the patients treated with intravenous rehydration therapy, to reduce symptoms or 
suffering was a treatment goal (versus 74% of the patients treated with antibiotics only).  
 With DS-DAT scores between 9.2 and 10.5, the levels of directly observed discomfort 
were high at all intervals proximate to the decision. A mean level of discomfort of around 10 
points has been observed as a peak level with pneumonia in an older study in the Netherlands4 
and with fever in an older US study−only when comfort care was not provided.20 In the more 
recent Dutch PneuMonitor study, the highest mean DS-DAT score was 8.1 and occurred one 
day after diagnosis after which it decreased to a mean of 4.5 at day 10.21  
 Regarding potential effects of intravenous rehydration therapy, it is possible that two 
processes affect comfort in opposite directions: invasive procedures that induce discomfort, 
and antibiotics being more effective when combined with rehydration possibly resolving 
symptoms sooner, at least, in the context of probably inadequate treatment to relieve 
symptoms.6 The finding of high discomfort overall and the figure not showing a substantially 
lower discomfort over time without invasive rehydration therapy is in contrast to the earlier 
Dutch work,8 where directly observed discomfort decreased after a decision to withhold 
artificial nutrition and hydration (ANH). However, the Dutch study lacked a pre-decision 
discomfort assessment, lacked a comparison with treated patients, and the patients suffered 
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from various acute conditions, with only few suffering from a respiratory tract infection.5,8 
Later analyses found increased discomfort in dying patients who received rehydration 
therapy.5 In the current study, fewer patients died so we could not explore discomfort close to 
death, which might have been high also due to increased secretions that are not cleared 
anymore.  
 Antibiotics were withheld in 10% of cases, which was a lower percentage than found 
in patients with severe dementia in previous studies in the US (24%) and the Netherlands 
(33%), but hospitalization was equally rare as in the Netherlands.13 This may be related to the 
fact that in the Lombardy region, similar as in the Netherlands, physicians are on the staff. In 
the US study, 28% received invasive rehydration, which was, however, strongly associated 
with hospitalization. Other studies have also shown that the Italian setting is dissimilar 
regarding treatment of intake problems, for example, Italian physicians were the least likely to 
forgo ANH (not specific to dementia) compared with five other European countries.22 In a 
survey, Valentini et al.23 found that most Italian physicians (74%) agreed with the provision 
of artificial hydration in patients with advanced dementia, and support was substantially 
greater than for artificial nutrition (42%), which has been studied far more often than artificial 
hydration in dementia. Hypodermoclysis, however, which is short-lived and more generally 
accepted in case of infections in dementia,1,24 was uncommon in our study. 
 We found that the providing of intravenous rehydration therapy was associated with a 
comfort goal and a poor prognosis. This is surprising; some assume that rehydration therapy 
is not for comfort. For example, a recent Dutch study reported on the practice of withholding 
of ANH in older people and the authors suggested it was often withheld because the 
physicians wanted to avoid “burdensome treatment solely to prolong life.”25 Valentini et al. 
suggest that, in Italy, rehydration is regarded as basic care. Solarino et al.,26 in another survey 
involving 22,219 Italian physicians, found divergence among the physicians as 37% of 
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respondents considered ANH as a basic need (“only a life-sustaining measure;” 61% regarded 
ANH a medical treatment, and 2% was unsure). Miccinesi et al.,27 in a 6-country study about 
palliative sedation in the general population, found that when provided, it was mostly with 
artificial nutrition and hydration in Italy and Belgium, but mostly without in Denmark, 
Sweden, The Netherlands and Switzerland. As also found in the study comparing Italy with 
other countries,22 the physicians often made the decision without discussing it with nursing 
staff or other physicians. Physicians who are on the staff may be more paternalistic than 
physicians with more distant practices as suggested by US-Dutch cross national work,28 but 
we found that in Italy, there was also little shared decision making with nurses and with 
families, unlike in the Netherlands.29 This, however, may not be uncommon or unique to Italy 
as a recent US study found that US families were often unaware of nursing home patients 
with advanced dementia experiencing a respiratory tract infection, and were not involved in 
decision making.30 Internationally, there is no consensus about providing artificial hydration 
in dementia in the dying phase and our study increases understanding of how hydration may 
be perceived as a comfort measure. 
Treatment to relieve symptoms was rarely provided in the current Italian study, for 
example, only 4.5% of the patients enrolled in the study with FAST 7c or higher (which 
applied to 87% of the patients with pneumonia) received paracetamol (acetaminophen) at 
baseline and 4.9% received opioids.15 No patients received new restraints at the time of the 
decisions, but 49% already had abdominal restraints at baseline and 16% already had 
rehydration therapy at baseline.  
 
Limitations and Strengths 
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The analyses were limited to a single region in Italy where physicians are on the staff, while 
other regions employ other models such as with fewer and smaller nursing homes but more 
home care, or with general practitioners visiting nursing homes. We focused on critical 
decisions which were decisions perceived as important with regard to survival and quality of 
life. The incidence of decisions around pneumonia in our study was 0.84 per year, which was 
rather high compared to incidence of nursing home-acquired pneumonia more generally (0.1 
to 0.9 episodes per year)31 which suggest that our approach is unlikely to have resulted in 
missing of many cases of pneumonia. We did not collect data on fluid intake. We also did not 
ask physicians to report the type of medication to relieve symptoms, and we asked to report 
any other treatment with an open-ended item, which might have resulted in underreporting of 
medication to relieve symptoms. However, medication to relieve symptoms was equally rare 
in the baseline assessment where we inventoried all medication provided which suggests that 
under treatment to relieve symptoms is a genuine concern. 
 The Italian prospective EoLO PSODEC study provided unique data on discomfort, 
with, to our best knowledge, the only directly observed assessments of discomfort ahead of a 
decision or treatment, and more such studies are recommended.32 The data do not allow for 
answering ethical or other questions about benefit from rehydration therapy. From 
observational data, we cannot conclude whether invasive rehydration therapy affects 
discomfort. Discomfort was not observed at the time of the decision, and the exact date of the 
decision was not recorded. Variable time between the decision and the discomfort 
assessments probably explains that we did not observe a high peak of discomfort in the period 
in which the decision was made. Nevertheless, previous work found that mean discomfort 
returned to stable levels within 10 days4,21 and in line with this, similar discomfort levels 
before and after the period in which the patient experienced the pneumonia suggest that 
elevated discomfort as a result of the pneumonia or its treatment, if any, does not persist. It is 
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possible that patients who received rehydration therapy had more symptoms or suffered more 
before the pneumonia, but the course of discomfort suggests there were no major differences. 
Although the EoLO PSODEC study followed as many as 496 cases, the power for comparing 
treatment groups was insufficient and we therefore refrained from testing difference between 
treatment groups. This illustrates the difficulty of efficiently assessing discomfort ahead of 
incident pneumonia and this may explain why this, to our best knowledge, has not been done 
before. 
 
Conclusion 
Our findings are important for a debate on the utility of invasive rehydration therapy in 
patients with advanced dementia, because, compared to feeding tubes, controversies around 
artificial rehydration therapy that exist across the world, is a relatively unexplored area. 
Regarding Italian nursing home patients with dementia and pneumonia, there is room to 
decrease high discomfort levels by providing treatment that probably improves comfort, in 
line with palliative treatment goals. New work should not limit to a focus on inappropriate 
life-prolonging treatment, but focus on comfort enhancing pharmacological as well as non-
pharmacological treatment. It should examine treatment goals in more detail, such as possible 
relief of feelings of thirst, or increase the effectiveness of antibiotics, and future intervention 
studies should consider how to address beliefs that may be rooted deeply in some cultures. 
Our study in which discomfort was observed directly several times around the decision, and 
taking into account antibiotics and proximity to death, needs to be replicated with larger 
sample sizes, more frequent independent observations and in settings with different treatment 
practices and populations varying in antibiotic use, prognosis, and dementia severity. Patient, 
family and professional caregivers’ perspectives on benefits of rehydration therapy may be 
examined more in-depth with qualitative research. In the absence of clear evidence on its 
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possible life-prolonging effects and unclear effects on discomfort in patients with advanced 
dementia and pneumonia, local policies regarding rehydration therapy may be developed 
which take into account goals of care and sensitives and perceptions about how patients may 
benefit from fluid therapy. 
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Table 1. Patient Characteristics and Treatments in 109 Decisions in 77 Patients with 
Advanced Dementia and Pneumonia. 
 Total 
(n = 
109) 
 
Antibiotics 
– new iv 
rehydration 
(n = 47) 
Antibiotics 
– no new iv 
rehydration 
(n=39)  
P 
Baseline  characteristics      
Female, % 72 74 79 .58 
Age, mean (SD) 84.9 
(8.4) 
85.8 (8.4) 83.6 (7.6) .21 
Type of dementia, % 
-Alzheimer 
-vascular 
-mixed Alzheimer-vascular 
-any other type or combination 
FAST 7c or higher (versus a or 
b), % 
 
39 
38 
17 
6 
87 
 
32 
49 
17 
2 
85 
 
54 
31 
8 
7 
87 
 
.07 
 
 
 
.78 
Treatment, % 
Iv rehydration therapy at baseline 
Treatment new / changes, % 
 
11 
 
NA 
 
NA 
 
Iv rehydration therapy 
-started 
-stopped 
 
53 
2 
 
all 
0 
 
no 
0 
 
NA 
NA 
Hypodermoclysis 
-started 
-stopped 
 
4 
0 
 
6 
0 
 
0 
0 
 
.25 
NA 
Tube feeding (nasogastric, PEG) 
-started 
-stopped 
 
1 
2 
 
0 
2 
 
0 
0 
 
NA 
1.0 
Hospitalization 1 2 0 1.0 
Restraintsa 
-started 
-stopped 
 
0 
0 
 
0 
0 
 
0 
0 
 
NA 
NA 
Blood transfusion 
-started  
-stopped 
 
1 
0 
 
2 
0 
 
0 
0 
 
1.0 
NA 
Sedation 
-started 
-stopped 
 
2 
3 
 
0 
2 
 
0 
5 
 
NA 
0.59 
Terminal sedation 
-started 
-stopped 
 
1 
0 
 
2 
0 
 
0 
0 
 
1.0 
NA 
Other interventionsb  
-started (e.g., oxygen,  
medication) 
-stopped (e.g., nutritional 
supplements, medication) 
 
9 
 
8 
 
9 
 
13 
 
8 
 
5 
 
1.0 
 
.28 
Not any intervention started or 
stopped 
1 (1 
case) 
0 0 NA 
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Abbreviations: Iv, intravenous; PEG, percutaneous endoscopic gastrostomy. 
 aNote that restraint use was unchanged around the decisions, but that restraints were probably 
already in use shortly before the decision, as baseline use was high overall, in the full sample 
of nursing home patients with FAST 7c or higher (93% any restraint; 49% abdominal 
restraints).15  
bOther interventions from open-ended item. Oxygen therapy started in five cases. In the other 
cases, medication was added:  heparin, cortisone, anti-Parkinson medication. Decisions to 
stop included nutritional supplements, all oral medication, all medication except fentanyl and 
morphine. 
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Table 2. Prognosis and Decision Making (n = 109 Decisions in 77 Patients with Advanced 
Dementia and Pneumonia). 
Prognosis and decision making 
according to physician 
interview, % 
Total 
(n = 109) 
Antibiotics 
– new iv 
rehydratio
n (n = 47) 
Antibiotics 
– no new 
iv 
rehydratio
n (n=39)  
P 
Prognosis, %  
Less than 15 days according to 
the physician (3 missing values) 
21 34 5 .001 
Aim(s) (more possible; 2 
missing values due to missing 
interview)b 
-to reduce symptoms/suffering 
-to prolong life 
-to avoid/stop futile treatment 
-to avoid prolonging life 
-to make the process of dying 
smoother  
 
Number of aims, median (range) 
 
 
89 
34 
7 
6 
 
3 
 
1 (1-3) 
 
 
96 
34 
9 
6 
 
2 
 
1 (1-3) 
 
 
74 
42 
3 
0 
 
0 
 
1 (1-2) 
 
 
.005 
.50 
.37 
.25 
 
1.0 
 
NSa 
Decision discussed with family 
or legal representative according 
to physician (4 missing values) 
49 54 27 .01 
Decision communicated to 
family or legal representative 
before or after the decision, 
according to physician (3 
missing values)  
89 89 84 .45 
Person who took the final 
decision (4 missing values)c 
-physician in full autonomy 
-physician guided by family or 
legal representative 
-the health care team 
-nurse only 
-others (physician on duty or 
missing specification) 
 
 
67 
 
7 
23 
2 
 
2 
 
 
62 
 
11 
23 
2 
 
2 
 
 
67 
 
3 
23 
3 
 
3 
 
 
.65 
aDistributions were the same; non-parametric p-value could not be computed. 
bThe option “other aim” was not chosen (0%). 
cThe following response options were not chosen (0%): physician in consultation with 
specialist, physician guided by patient (advance directive, previous discussions), and-the 
family or legal representative  only. 
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Figure 1. Selection of patients and decisions for description of treatment and decision 
making, and discomfort 
181 
patients  with home care 
        
       
   
  
     
      
 
 
 
 
315 
nursing home patients   
77 
patients with any pneumonia, 
involving 
109 
episodes / decisions 
238 
patients  no pneumonia 
98 
episodes / decisions  
with antibiotic treatment 
11 
episodes / decisions  
antibiotic treatment not 
started (9) or stopped (2) 
86 
episodes / decisions  
about iv rehydration (47 new, 
39 no new iv rehydration) 
12 
episodes / decisions  
baseline iv rehydration 
45 
first episodes / decisions  
about iv rehydration included 
in description of discomfort 
(23 new, 22 no new iv 
rehydration) 
41  
episodes / decisions  
about iv rehydration, second 
decisions and first decisions 
with <3 consecutive 
discomfort assessments or 
died in the fortnight 
afterwards 
496 
patients  enrolled 
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Figure 2. Discomfort around the time of the first pneumonia decision and by the decision to 
provide or withhold intravenous rehydration therapy. The same period covers the period in 
which the decision was made. 
 
Notes. The mean DS-DAT score during the period of the decision for all 109 decisions was 
10.8 SD 7.0 (13 missing values) and for the 77 first decisions, it was 10.5 (SD 7.1; 10 missing 
values). To avoid presenting overlapping periods, the figure shows patterns of the first 77 
decisions only. Further, 45 decisions referred to decisions to treat with antibiotics, and with 
three consecutive discomfort assessments and not followed by death in the fortnight 
afterwards, and with no intravenous rehydration therapy at baseline. Statistical test results are 
not provided because of insufficient power. 
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